Why do older women discontinue hormone replacement therapy?

Journal of Women’s Health and Gender-Based Medicine

Volumn 10, Issue 4, 2001, Pages 343-350

  Regan, Meredith M ^a,b   Parker, Robert A ^a,b   Greenspan, Susan L ^a,c   Emond, Sarah K ^b   Attardo, Mary J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; MEDROXYPROGESTERONE; MULTIVITAMIN; PLACEBO; SEX HORMONE;

AGED; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIARRHEA; DRUG WITHDRAWAL; EDEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MIGRAINE; NAUSEA; OSTEOPOROSIS; PHLEBITIS; POSTMENOPAUSE; PRIORITY JOURNAL; SIDE EFFECT; SPOTTING; VAGINA BLEEDING; VERTIGO; VOMITING; WATER RETENTION; WEIGHT GAIN;

AGED; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; TREATMENT REFUSAL;

EID: 0034779062     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460901750269661     Document Type: Article

References (13)

1. Estrogen replacement therapy: A survey of older women’s attitudes
2. Women’s beliefs and decisions about hormone replacement therapy
3. Use of the progestogen challenge test to reduce the risk of endometrial cancer
4. Effects of long-term estrogen replacement therapy. Part II. Neoplasia
5. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens
6. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy
7. Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient
8. Continuous estrogen/progestin therapy in menopause
9. A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement
10. Five years with continuous combined oestrogen/progestogen therapy: Effects on calcium metabolism, lipoproteins, and bleeding patterns
11. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation
12. Achieving long-term continuance of menopausal ERT/HRT: Consensus opinion of the North American Menopause Society
13. Effect of age on reasons for initiation and discontinuation of hormone replacement therapy